Foundation Medicine spotlights scientific achievements at ESMO Congress in 11 abstracts, including one oral presentation, across seven cancer types.
A doctor has warned that taking a common medication for longer than six months can lead to a number of concerning side ...
With the NMPA's approval, Mirxes will significantly scale up the commercialization of GASTROClear™ in China. The company ...
The non-invasive blood test helps in the early detection of the fifth leading cause of cancer deaths globally.
MedPage Today on MSN
For Your Patients: Here's How Stomach Cancer Is Diagnosed
Importantly, stomach cancer is also being diagnosed in an increasing number of younger people -- that is, those younger than 50. In 2019, these cancers -- also called early-onset -- accounted for ...
Mirxes Holding Company Limited ( ($HK:2629) ) just unveiled an update. Mirxes Holding Company Limited announced that its core product, ...
Adding an esophagogastroduodenoscopy to a screening or surveillance colonoscopy detected upper-GI cancers and preneoplastic ...
The European Society for Medical Oncology "Living Guideline" for Gastric Cancer suggests that narrow-band imaging or ...
Galleri Test, pioneered by GRAIL, dominated the market with over 40% share (US$ 770 million in 2024). Its ability to detect ...
The company recently reported that the four-protein test with algorithm-based analysis performed with 83.5 percent sensitivity and 90.3 percent specificity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback